Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Ultrasound-guided LCNB of breast lesions for reliable tumor classification
March 31st, 2005
The number of ultrasound-guided LCNB needed for reliable tumor classification has been assessed. According to a study from Germany, "The objective of this one-institutional study was to determine the number of large-core needle biopsies (LCNB), under three-dimensional ultrasound (3D-US) validation, that are sufficient to obtain a reliable histological diagnosis of a sonographically detectable breast lesion." "Over a 28-month period, 962 sonographically guided LCNB were performed under 3D-US validation to assess 962 breast lesions. All biopsies were carried out with an automated core biopsy device fitted with 14-gauge (22-mm excursion) needles," said...
Source: Women's Health Weekly (2005-03-31)
|
